Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC)
Article in Oral Oncology (August 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Oral Oncology (August 2024)
Article in Frontiers in Oncology (February 2024)
Article in Head & Neck (December 2023)